Skip to content

Clinical trials

Phase 3 Cardiovascular Diseases trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 3 Country / region: Italy Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20051
20061
20072
20082
20091
20103
20112
20123
20132
20141
20161
20171
20182
20193
20222
20233
20242
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Terminated8
Recruiting6
Active, not recruiting5
Unknown status2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals7
GlaxoSmithKline4
Eli Lilly and Company3
Amgen2
AstraZeneca2
Pfizer2
Sanofi2
United Therapeutics2
Alnylam Pharmaceuticals1
Azienda Ospedaliera San Camillo Forlanini1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases42
Myocardial Infarction10
Stroke9
Heart Diseases8
Atherosclerosis7
Diabetes Mellitus, Type 27
Hypertension7
Heart Failure5
Acute Coronary Syndrome4
Hyperlipidemias4

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.